TARSUS PHARMACEUTICALS, INC. (TARS) Free cash flow 2019–2025
TARSUS PHARMACEUTICALS, INC. (TARS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$22.3MFY2025 · since FY2019: -$3.8M → -$22.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.3M | +73.6% |
| FY2024 | -$84.6M | +28.9% |
| FY2023 | -$119.0M | -140.2% |
| FY2022 | -$49.5M | -1666.6% |
| FY2021 | $3.2M | +114.6% |
| FY2020 | -$21.6M | -461.2% |
| FY2019 | -$3.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TARS financial trends
TARS RevenueTARS Net incomeTARS Net marginTARS Gross profitTARS Gross marginTARS Operating incomeTARS Operating marginTARS Operating cash flowTARS Capital expendituresTARS Return on equityTARS Stock buybacksTARS Dividends paidTARS Total assetsTARS Total liabilitiesTARS Shareholders’ equityTARS overview →